retatrutide weight loss trials Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Air Mail | On TikTok,
Description
The first randomised controlled trial of semaglutide for alcohol use disorder, published in JAMA Psychiatry in 2025, found that people taking low doses had fewer heavy drinking days, fewer cravings, and reduced alcohol intake compared to placebo
Learn how to manage nausea, dry mouth, and constipation while on weight loss injections.
Adding Testosterone and Anavar preserves lean mass
A letter in JCP responding to McIntyre's GLP-1 commentary proposes a -cellcentric view especially for Asian populations where the danger is pancreatic -cell failure
Compounded, Why GLP-1s Help with Hypothyroidism, How to Make GLP-1s Work for You
